Molecular Tumor Board: 77-year-old female with a history of ER+/PR+/HER2- right breast cancer and new lung mass with EGFR exon 19 deletion and ALK fusion Skip to main contentScroll Back to Top
Our global life sciences company brings diagnostic testing & drug development together.
Molecular Tumor Board: 77-year-old female with a history of ER+/PR+/HER2- right breast cancer and new lung mass with EGFR exon 19 deletion and ALK fusion